ticker,nameOfIssuer,cusip,value,shares,allocation_percent,filingDate,reportDate,accessionNumber
2L9,BLUEPRINT MEDICINES CORP,09627Y109,84070000.0,2102280,14.299224062564846,2017-05-15,2017-03-31,0000921895-17-001513
CCXIEUR,CHEMOCENTRYX INC,16383L106,58171000.0,7990572,9.894137777369568,2017-05-15,2017-03-31,0000921895-17-001513
CYTK,CYTOKINETICS INC,23282W605,54752000.0,4260836,9.31260991880041,2017-05-15,2017-03-31,0000921895-17-001513
ANAB,ANAPTYSBIO INC,032724106,48246000.0,1738600,8.206023125044648,2017-05-15,2017-03-31,0000921895-17-001513
CNCEEUR,CONCERT PHARMACEUTICALS INC,206022105,39863000.0,2336609,6.780182809635095,2017-05-15,2017-03-31,0000921895-17-001513
CTMX,CYTOMX THERAPEUTICS INC,23284F105,31167000.0,1804675,5.301105226096807,2017-05-15,2017-03-31,0000921895-17-001513
N/A,FORWARD PHARMA A/S,34986J105,29908000.0,1387853,5.086965543751509,2017-05-15,2017-03-31,0000921895-17-001513
INFIQ,INFINITY PHARMACEUTICALS INC,45665G303,25408000.0,7866108,4.321573509951797,2017-05-15,2017-03-31,0000921895-17-001513
ARRYEUR,ARRAY BIOPHARMA INC,04269X105,24702000.0,2763086,4.201492004204554,2017-05-15,2017-03-31,0000921895-17-001513
CTIC1USD,CTI BIOPHARMA CORP,12648L601,18815000.0,4479691,3.2001891368759074,2017-05-15,2017-03-31,0000921895-17-001513
N/A,BIOLINERX LTD SPONSORED,09071M106,16809000.0,17500000,2.8589943769198585,2017-05-15,2017-03-31,0000921895-17-001513
N/A,ONCOMED PHARMACEUTICALS INC,68234X102,16214000.0,1760489,2.757792541339674,2017-05-15,2017-03-31,0000921895-17-001513
N/A,GLYCOMIMETICS INC,38000Q102,15347000.0,2826282,2.610327009494263,2017-05-15,2017-03-31,0000921895-17-001513
ACHNEUR,ACHILLION PHARMACEUTICALS INC COM,00448Q201,13832000.0,3285400,2.352645024781693,2017-05-15,2017-03-31,0000921895-17-001513
N/A,LOXO ONCOLOGY INC,548862101,13466000.0,320000,2.290393139365983,2017-05-15,2017-03-31,0000921895-17-001513
N/A,CASCADIAN THERAPEUTICS INC,14740B606,12972000.0,3133224,2.206370102766637,2017-05-15,2017-03-31,0000921895-17-001513
XENE,XENON PHARMACEUTICALS INC,98420N105,11799000.0,2949794,2.0068579126228454,2017-05-15,2017-03-31,0000921895-17-001513
XOMA,XOMA CORP DEL,98419J206,10685000.0,1502800,1.8173808624777612,2017-05-15,2017-03-31,0000921895-17-001513
FATE,FATE THERAPEUTICS INC,31189P102,8851000.0,1945245,1.5054410869247228,2017-05-15,2017-03-31,0000921895-17-001513
N/A,IMMUNE DESIGN CORP,45252L103,8391000.0,1233976,1.42720101235853,2017-05-15,2017-03-31,0000921895-17-001513
ARQLUSD,ARQULE INC,04269E107,7844000.0,7400128,1.3341633584722095,2017-05-15,2017-03-31,0000921895-17-001513
SNSSEUR,SUNESIS PHARMACEUTICALS INC,867328700,6315000.0,1540323,1.0741001540989294,2017-05-15,2017-03-31,0000921895-17-001513
OREXQ 2.75 12/01/20,OREXIGEN THERAPEUTICS INC,686164AB0,5475000.0,10000000,0.9312269744563166,2017-05-15,2017-03-31,0000921895-17-001513
N/A,NIVALIS THERAPEUTICS INC,65481J109,5444000.0,1864474,0.9259542737790296,2017-05-15,2017-03-31,0000921895-17-001513
N/A,GTX INC DEL,40052B207,5387000.0,1108433,0.9162593080175666,2017-05-15,2017-03-31,0000921895-17-001513
N/A,PIERIS PHARMACEUTICALS INC,720795103,4984000.0,1917033,0.8477141992128367,2017-05-15,2017-03-31,0000921895-17-001513
N/A,ANTHERA PHARMACEUTICALS INC,03674U201,3426000.0,8052073,0.5827184683995142,2017-05-15,2017-03-31,0000921895-17-001513
N/A,OREXIGEN THERAPEUTICS INC,686164302,2528000.0,734976,0.4299802358768161,2017-05-15,2017-03-31,0000921895-17-001513
N/A,PAIN THERAPEUTICS INC,69562K100,2035000.0,2278552,0.3461272863960921,2017-05-15,2017-03-31,0000921895-17-001513
N/A,REGULUS THERAPEUTICS INC,75915K101,1028000.0,623000,0.1748495579435787,2017-05-15,2017-03-31,0000921895-17-001513
